Search Results 311-320 of 16763 for immunothérapie effets secondaires
This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
Mayo Clinic expert highlights improved survival in muscle-invasive bladder cancer and kidney cancer featured · Study identifies potential immunotherapy strategy ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
Late-breaking abstract at SUO: Novel oncolytic immunotherapy shows promise for patients with bladder cancer. Kelley Luckstein. December 5, 2024. Mayo Clinic ...
Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers featured image. Arizona. Mayo Clinic ...
Study identifies potential immunotherapy strategy for early-stage prostate cancer featured image ... Mayo Clinic study identifies mechanism behind immunotherapy ...
Mayo Clinic study identifies mechanism behind immunotherapy resistance in lung cancer. PHOENIX — Mayo Clinic researchers and collaborators have identified a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!